5:41 PM
 | 
Feb 12, 2013
 |  BC Extra  |  Company News

Genentech, Avalon's RQx in discovery deal

Genentech Inc. partnered with RQx Pharmaceuticals Inc. (San Diego, Calif.) to discover and develop compounds against an undisclosed target. RQx is eligible to receive up to $111 million in an undisclosed upfront payment and milestones,...

Read the full 164 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >